Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Bladder Cancer

  Free Subscription


Articles published in BJU Int

Retrieve available abstracts of 76 articles:
HTML format
Text format



Single Articles


    November 2017
  1. AHMADI N, Clifford TG, Miranda G, Cai J, et al
    Impact of body mass index on robot-assisted radical cystectomy with intracorporeal urinary diversion.
    BJU Int. 2017;120:689-694.
    PubMed     Text format     Abstract available


  2. HUDDART RA, Birtle A, Maynard L, Beresford M, et al
    Clinical and patient-reported outcomes of SPARE - a randomised feasibility study of selective bladder preservation versus radical cystectomy.
    BJU Int. 2017;120:639-650.
    PubMed     Text format     Abstract available


  3. KINNEAR N, Smith R, Hennessey DB, Bolton D, et al
    Implementation rates of uro-oncology multidisciplinary meeting decisions.
    BJU Int. 2017;120 Suppl 3:15-20.
    PubMed     Text format     Abstract available


    October 2017
  4. XIA L, Taylor BL, Newton AD, Malhotra A, et al
    Early Discharge and Post-Discharge Outcomes in Patients Undergoing Radical Cystectomy for Bladder Cancer.
    BJU Int. 2017 Oct 24. doi: 10.1111/bju.14058.
    PubMed     Text format     Abstract available


  5. SMITH AB, Jaeger B, Pinheiro LC, Edwards LJ, et al
    The impact of bladder cancer on health-related quality of life.
    BJU Int. 2017 Oct 8. doi: 10.1111/bju.14047.
    PubMed     Text format     Abstract available


    September 2017
  6. PICHLER R, Fritz J, Tulchiner G, Klinglmair G, et al
    Increased Accuracy of a novel mRNA-based Urine Test for Bladder Cancer Surveillance.
    BJU Int. 2017 Sep 20. doi: 10.1111/bju.14019.
    PubMed     Text format     Abstract available


  7. VETTERLEIN MW, Gild P, Kluth LA, Seisen T, et al
    Perioperative Allogeneic Blood Transfusion Does Not Adversely Impact Oncological Outcomes After Radical Cystectomy for Urinary Bladder Cancer - a Propensity Score-weighted European Multicenter Study.
    BJU Int. 2017 Sep 14. doi: 10.1111/bju.14012.
    PubMed     Text format     Abstract available


  8. LI R, Metcalfe MJ, Ferguson Rd JE, Mokkapati S, et al
    Effects of Thiazolidinedione in Patients with Active Bladder Cancer.
    BJU Int. 2017 Sep 5. doi: 10.1111/bju.14009.
    PubMed     Text format     Abstract available


  9. DUDDERIDGE T
    Positive messages for bladder cancer management in negative sentinel lymph node study.
    BJU Int. 2017;120:302-303.
    PubMed     Text format    


  10. MARCHIONI M, Primiceri G, Cindolo L, Hampton LJ, et al
    Impact of diagnostic ureteroscopy on intravesical recurrence in patients undergoing radical nephroureterectomy for upper tract urothelial cancer: a systematic review and meta-analysis.
    BJU Int. 2017;120:313-319.
    PubMed     Text format     Abstract available


  11. BLUTE ML JR, Kucherov V, Rushmer TJ, Damodaran S, et al
    Reduced estimated glomerular filtration rate (eGFR <60 mL/min/1.73 m2 ) at first transurethral resection of bladder tumour is a significant predictor of subsequent recurrence and progression.
    BJU Int. 2017;120:387-393.
    PubMed     Text format     Abstract available


  12. CHAPPIDI MR, Kates M, Tosoian JJ, Johnson MH, et al
    Evaluation of gender-based disparities in time from initial haematuria presentation to upper tract urothelial carcinoma diagnosis: analysis of a nationwide insurance claims database.
    BJU Int. 2017;120:377-386.
    PubMed     Text format     Abstract available


    August 2017
  13. WAINGANKAR N, Mallin K, Smaldone M, Egleston BL, et al
    Assessing the relative influence of hospital and surgeon volume on short-term mortality after radical cystectomy.
    BJU Int. 2017;120:239-245.
    PubMed     Text format     Abstract available


  14. MILLER C, Campain NJ, Dbeis R, Daugherty M, et al
    Introduction of robot-assisted radical cystectomy within an established enhanced recovery programme.
    BJU Int. 2017;120:265-272.
    PubMed     Text format     Abstract available


    June 2017
  15. MCCOMBIE SP, Bangash HK, Kuan M, Thyer I, et al
    Delays in the diagnosis and initial treatment of bladder cancer in Western Australia.
    BJU Int. 2017 Jun 29. doi: 10.1111/bju.13939.
    PubMed     Text format     Abstract available


  16. AFSHAR M, Goodfellow H, Jackson-Spence F, Evison F, et al
    Centralisation of radical cystectomies for bladder cancer in England, a decade on from the 'Improving Outcomes Guidance': The case for super centralisation.
    BJU Int. 2017 Jun 8. doi: 10.1111/bju.13929.
    PubMed     Text format     Abstract available


  17. SOAVE A, Riethdorf S, Dahlem R, Minner S, et al
    Detection and oncological effect of circulating tumour cells in patients with variant urothelial carcinoma histology treated with radical cystectomy.
    BJU Int. 2017;119:854-861.
    PubMed     Text format     Abstract available


    May 2017
  18. NGO B, Papa N, Perera M, Bolton D, et al
    Bladder cancer diagnosis during haematuria investigation - implications for practice guidelines.
    BJU Int. 2017;119 Suppl 5:53-54.
    PubMed     Text format    


  19. HAYNE D
    Bladder cancer - Old lessons yet to be learned.
    BJU Int. 2017;119 Suppl 5:7.
    PubMed     Text format    


  20. NGO B, Perera M, Papa N, Bolton D, et al
    Factors affecting the timeliness and adequacy of haematuria assessment in bladder cancer: a systematic review.
    BJU Int. 2017;119 Suppl 5:10-18.
    PubMed     Text format     Abstract available


  21. LAWRENTSCHUK N
    Bladder cancer- time for a higher profile in our region.
    BJU Int. 2017;119 Suppl 5:5.
    PubMed     Text format    


  22. NGO B, Papa N, Perera M, Bolton D, et al
    Predictors of delay to cystoscopy and adequacy of investigations in patients with haematuria.
    BJU Int. 2017;119 Suppl 5:19-25.
    PubMed     Text format     Abstract available


    April 2017
  23. HAYNE D, Stockler M, McCombie SP, Lawrence N, et al
    The BCG + Mitomycin trial for high risk non-muscle-invasive bladder cancer: Progress report and lessons learned.
    BJU Int. 2017 Apr 9. doi: 10.1111/bju.13873.
    PubMed     Text format     Abstract available


  24. BAILEY GC, Boorjian SA, Ziegelmann MJ, Westerman ME, et al
    Urinary collecting system invasion is associated with poor survival in patients with clear-cell renal cell carcinoma.
    BJU Int. 2017;119:585-590.
    PubMed     Text format     Abstract available


  25. HINATA N, Hussein AA, George S, Trump DL, et al
    Impact of suboptimal neoadjuvant chemotherapy on peri-operative outcomes and survival after robot-assisted radical cystectomy: a multicentre multinational study.
    BJU Int. 2017;119:605-611.
    PubMed     Text format     Abstract available


    February 2017
  26. VESKIMAE E, Neuzillet Y, Rouanne M, MacLennan S, et al
    Systematic review of the oncological and functional outcomes of pelvic organ-preserving cystectomy compared with standard radical cystectomy in women who undergo curative surgery and orthotopic neobladder substitution for bladder cancer.
    BJU Int. 2017 Feb 20. doi: 10.1111/bju.13819.
    PubMed     Text format     Abstract available


    January 2017
  27. WOLDU SL, Bagrodia A, Lotan Y
    Guideline of Guidelines - Non-Muscle Invasive Bladder Cancer.
    BJU Int. 2017 Jan 6. doi: 10.1111/bju.13760.
    PubMed     Text format     Abstract available


  28. GOLOMBOS DM, O'Malley P, Lewicki P, Stone BV, et al
    Robot-assisted partial cystectomy: perioperative outcomes and early oncological efficacy.
    BJU Int. 2017;119:128-134.
    PubMed     Text format     Abstract available


    December 2016
  29. HUSSEIN AA, Hinata N, Dibaj S, May PR, et al
    Development, Validation and Clinical Application of Pelvic Lymphadenectomy Assessment and Completion Evaluation (PLACE): Intraoperative Assessment of Lymph Node Dissection after Robot-Assisted Radical Cystectomy for Bladder Cancer.
    BJU Int. 2016 Dec 17. doi: 10.1111/bju.13748.
    PubMed     Text format     Abstract available


    October 2016
  30. ALJABERY F, Shabo I, Olson H, Gimm O, et al
    Radio-guided sentinel lymph node detection and lymph node mapping in invasive urinary bladder cancer-a prospective clinical study.
    BJU Int. 2016 Oct 31. doi: 10.1111/bju.13700.
    PubMed     Text format     Abstract available


  31. FERNANDEZ MI, Williams SB, Willis DL, Slack RS, et al
    Clinical Risk Stratification in Patients with Surgically Resectable Micropapillary Bladder Cancer.
    BJU Int. 2016 Oct 18. doi: 10.1111/bju.13689.
    PubMed     Text format     Abstract available


  32. MATARAZA JM, Gotwals P
    Recent advances in immuno-oncology and its application to urological cancers.
    BJU Int. 2016;118:506-14.
    PubMed     Text format     Abstract available


  33. LONGO N, Imbimbo C, Fusco F, Ficarra V, et al
    Complications and quality of life in elderly patients with several comorbidities undergoing cutaneous ureterostomy with single stoma or ileal conduit after radical cystectomy.
    BJU Int. 2016;118:521-6.
    PubMed     Text format     Abstract available


  34. ZHANG C, Ma X, Du J, Yao Z, et al
    MicroRNA-30a as a prognostic factor in urothelial carcinoma of bladder inhibits cellular malignancy by antagonising Notch1.
    BJU Int. 2016;118:578-89.
    PubMed     Text format     Abstract available


    July 2016
  35. ONISHI T, Sugino Y, Shibahara T, Masui S, et al
    Randomized controlled study of the efficacy and safety of continuous saline bladder irrigation after transurethral resection for the treatment of non-muscle invasive bladder cancer.
    BJU Int. 2016 Jul 22. doi: 10.1111/bju.13599.
    PubMed     Text format     Abstract available


  36. LOTAN Y
    Analysis of genetics to identify susceptibility to secondary malignancies in patients with bladder cancer.
    BJU Int. 2016;118:12-3.
    PubMed     Text format    


  37. MOSTAFID AH
    Time to re-evaluate and refine re-transurethral resection in bladder cancer?
    BJU Int. 2016;118:9-10.
    PubMed     Text format    


    June 2016
  38. CUMBERBATCH MG, Shellard BW, Catto JW
    The contemporary landscape of occupational bladder cancer within the United Kingdom: A meta-analysis of risks over the last 80 years.
    BJU Int. 2016 Jun 22. doi: 10.1111/bju.13561.
    PubMed     Text format     Abstract available


  39. MEYER CP, Rios Diaz AJ, Dalela D, Hanske J, et al
    Wound dehiscence in a sample of 1 776 cystectomies: identification of predictors and implications for outcomes.
    BJU Int. 2016;117.
    PubMed     Text format     Abstract available


    May 2016
  40. HURLE R, Pasini L, Lazzeri M, Colombo P, et al
    Active surveillance for low-risk Non-Muscle Invasive Bladder Cancer (NMIBC): mid-term results from a Bladder cancer Italian Active Surveillance (BIAS) project.
    BJU Int. 2016 May 21. doi: 10.1111/bju.13536.
    PubMed     Text format     Abstract available


  41. KAMAT AM, Willis DL, Dickstein RJ, Anderson R, et al
    Novel fluorescence in situ hybridization-based definition of bacille Calmette-Guerin (BCG) failure for use in enhancing recruitment into clinical trials of intravesical therapies.
    BJU Int. 2016;117:754-60.
    PubMed     Text format     Abstract available


    April 2016
  42. VARTOLOMEI MD, Kiss B, Vidal A, Burkhard F, et al
    Long-term results of a prospective randomized trial assessing the impact of re-adaptation of the dorsolateral peritoneal layer after extended pelvic lymph node dissection and cystectomy.
    BJU Int. 2016;117:618-28.
    PubMed     Text format     Abstract available


  43. CHEN EC, Papa N, Lawrentschuk N, Bolton D, et al
    Incidence and risk factors of venous thromboembolism after pelvic uro-oncologic surgery--a single center experience.
    BJU Int. 2016;117 Suppl 4:50-3.
    PubMed     Text format     Abstract available


    March 2016
  44. YADAV S, Tomar V, Yadav SS, Priyadarshi S, et al
    Role of oral PentosanPolysulphate in reduction of local side effects of BCG in Non muscle invasive Bladder Cancer patients: a pilot study.
    BJU Int. 2016 Mar 24. doi: 10.1111/bju.13489.
    PubMed     Text format     Abstract available


  45. ODDENS JR, Sylvester RJ, Brausi MA, Kirkels WJ, et al
    Increasing age is not associated with toxicity leading to discontinuation of treatment in urothelial non muscle invasive bladder cancer patients randomized to receive 3 years of maintenance bacillus Calmette-Guerin: Results from EORTC GU Group study 3
    BJU Int. 2016 Mar 6. doi: 10.1111/bju.13474.
    PubMed     Text format     Abstract available


  46. SATKUNASIVAM R, Hu B, Metcalfe C, Ghodoussipour SB, et al
    Utility and significance of ureteric frozen section analysis during radical cystectomy.
    BJU Int. 2016;117:463-8.
    PubMed     Text format     Abstract available


    February 2016
  47. SAMMON JD, Abdollah F, Klett DE, Pucheril D, et al
    The diminishing returns of robotic diffusion: complications after robot-assisted radical prostatectomy.
    BJU Int. 2016;117:211-2.
    PubMed     Text format    


  48. AZIZ A, Shariat SF, Roghmann F, Brookman-May S, et al
    Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making.
    BJU Int. 2016;117:272-9.
    PubMed     Text format     Abstract available


  49. ZEHNDER P, Moltzahn F, Mitra AP, Cai J, et al
    Radical cystectomy with super-extended lymphadenectomy: impact of separate vs en bloc lymph node submission on analysis and outcomes.
    BJU Int. 2016;117:253-9.
    PubMed     Text format     Abstract available


    December 2015
  50. KOUPPARIS A, Villeda-Sandoval C, Weale N, El-Mahdy M, et al
    Robot-assisted radical cystectomy with intracorporeal urinary diversion: impact on an established enhanced recovery protocol.
    BJU Int. 2015;116:924-31.
    PubMed     Text format     Abstract available


    November 2015
  51. ROLLE L, Falcone M, Ceruti C, Timpano M, et al
    A prospective multicentric international study on the surgical outcomes and patients' satisfaction rates of the "Sliding Technique" for end-stage Peyronie's disease with severe shortening of the penis and erectile dysfunction.
    BJU Int. 2015 Nov 11. doi: 10.1111/bju.13370.
    PubMed     Text format     Abstract available


  52. LOEB S, Ribal MJ
    Controversies in management of high-risk prostate and bladder cancer.
    BJU Int. 2015;116:675.
    PubMed     Text format    


  53. SKINNER EC
    Is 42 days the 'magic number' for repeat transurethral resection of bladder tumour (TURBT)?
    BJU Int. 2015;116:678-9.
    PubMed     Text format    


  54. TAN WS, Sridhar A, Goldstraw M, Zacharakis E, et al
    Robot-assisted intracorporeal pyramid neobladder.
    BJU Int. 2015;116:771-9.
    PubMed     Text format     Abstract available


  55. AL HUSSEIN AL AWAMLH B, Wang LC, Nguyen DP, Rieken M, et al
    Is continent cutaneous urinary diversion a suitable alternative to orthotopic bladder substitute and ileal conduit after cystectomy?
    BJU Int. 2015;116:805-14.
    PubMed     Text format     Abstract available


    October 2015
  56. GENDY R, Delprado W, Brenner P, Brooks A, et al
    Repeat transurethral resection for non-muscle-invasive bladder cancer: a contemporary series.
    BJU Int. 2015 Oct 21. doi: 10.1111/bju.13265.
    PubMed     Text format     Abstract available


  57. WARREN H, Raison N, Dasgupta P
    Pioglitazone and Bladder Cancer.
    BJU Int. 2015 Oct 15. doi: 10.1111/bju.13352.
    PubMed     Text format     Abstract available


  58. MULLER J, Grosclaude P, Lapotre-Ledoux B, Woronoff AS, et al
    Trends of the risk of second primary cancer among bladder cancer survivors: a population-based cohort of 10,047 patients.
    BJU Int. 2015 Oct 15. doi: 10.1111/bju.13351.
    PubMed     Text format     Abstract available


  59. RAMIREZ D, Gupta A, Canter D, Harrow B, et al
    Microscopic hematuria at time of diagnosis is associated with lower disease stage in patients with newly diagnosed bladder cancer.
    BJU Int. 2015 Oct 5. doi: 10.1111/bju.13345.
    PubMed     Text format     Abstract available


  60. IZQUIERDO L, Peri L, Leon P, Ramirez-Backhaus M, et al
    The role of cystectomy in elderly patients - a multicentre analysis.
    BJU Int. 2015;116 Suppl 3:73-9.
    PubMed     Text format     Abstract available


    September 2015
  61. VOSKOBOYNIK M, Rudman S, Arkenau HT, Hughes S, et al
    Immunotherapy for Bladder Cancer: Rediscovering an Old Friend.
    BJU Int. 2015 Sep 21. doi: 10.1111/bju.13330.
    PubMed     Text format     Abstract available


  62. PATEL MI, Bang A, Gillatt D, Smith DP, et al
    Contemporary radical cystectomy outcomes in patients with invasive bladder cancer: a population-based study.
    BJU Int. 2015 Sep 2. doi: 10.1111/bju.13152.
    PubMed     Text format     Abstract available


    August 2015
  63. ROSE JB, Armstrong S, Hermann GG, Kjellberg J, et al
    Budget impact of incorporating one instillation of hexaminolevulinate hydrochloride blue- light cystoscopy in trans-urethral bladder tumour resection for non-muscle invasive bladder cancer patients in Sweden.
    BJU Int. 2015 Aug 25. doi: 10.1111/bju.13261.
    PubMed     Text format     Abstract available


  64. WILLIAMS SB, Kamat AM, Lamm DL
    Pelvic recurrence after radical cystectomy: a call to arms.
    BJU Int. 2015;116:172-3.
    PubMed     Text format    


    July 2015
  65. O'REGAN T, Tatton M, Lyon M, Masters J, et al
    The effectiveness of BCG and interferon against non-muscle invasive bladder cancer: A New Zealand Perspective.
    BJU Int. 2015 Jul 14. doi: 10.1111/bju.13211.
    PubMed     Text format     Abstract available


  66. GAKIS G, Stenzl A
    Can we rely on lymphovascular invasion for determining the need for adjuvant chemotherapy in organ-confined bladder cancer?
    BJU Int. 2015;116:3-4.
    PubMed     Text format    


  67. WITJES JA
    Fluorescence cystoscopy: the end of biopsies for carcinoma in situ detection?
    BJU Int. 2015;116:2-3.
    PubMed     Text format    


  68. VON RUNDSTEDT FC, Mata DA, Groshen S, Stein JP, et al
    Significance of lymphovascular invasion in organ-confined, node-negative urothelial cancer of the bladder: data from the prospective p53-MVAC trial.
    BJU Int. 2015;116:44-9.
    PubMed     Text format     Abstract available


    June 2015
  69. ALBISINNI S, Rassweiler J, Abbou CC, Cathelineau X, et al
    Long-term analysis of oncological outcomes after laparoscopic radical cystectomy in Europe: results from a multicentre study by the European Association of Urology (EAU) section of Uro-technology.
    BJU Int. 2015;115:937-45.
    PubMed     Text format     Abstract available


    May 2015
  70. MCLATCHIE LM
    Could a dye offer a cheap and simple approach to detect bladder cancer using white-light cystoscopy?
    BJU Int. 2015 May 8. doi: 10.1111/bju.13177.
    PubMed     Text format     Abstract available


  71. LUCCA I, Roupret M, Kluth L, Rink M, et al
    Adjuvant cisplatin-based combined chemotherapy for lymph node (LN)-positive urothelial carcinoma of the bladder (UCB) after radical cystectomy (RC): a retrospective international study of >1500 patients.
    BJU Int. 2015;115:722-7.
    PubMed     Text format     Abstract available


  72. LEOW JJ, Reese S, Trinh QD, Bellmunt J, et al
    Impact of surgeon volume on the morbidity and costs of radical cystectomy in the USA: a contemporary population-based analysis.
    BJU Int. 2015;115:713-21.
    PubMed     Text format     Abstract available


  73. ISHIOKA J, Saito K, Kijima T, Nakanishi Y, et al
    Risk stratification for bladder recurrence of upper urinary tract urothelial carcinoma after radical nephroureterectomy.
    BJU Int. 2015;115:705-12.
    PubMed     Text format     Abstract available


    April 2015
  74. TOLCHARD S, Angell J, Pyke M, Lewis S, et al
    Cardiopulmonary reserve as determined by cardiopulmonary exercise testing correlates with length of stay and predicts complications after radical cystectomy.
    BJU Int. 2015;115:554-61.
    PubMed     Text format     Abstract available


  75. PHE V, Roupret M, Cussenot O, Chartier-Kastler E, et al
    Forkhead box protein P3 (Foxp3) expression serves as an early chronic inflammation marker of squamous cell differentiation and aggressive pathology of urothelial carcinomas in neurological patients.
    BJU Int. 2015;115 Suppl 6:28-32.
    PubMed     Text format     Abstract available


    December 2014
  76. BAACK KUKREJA JE, Scosyrev E, Brasacchio RA, Toy EP, et al
    Bladder cancer incidence and mortality in patients treated with radiation for uterine cancer.
    BJU Int. 2014;114:844-51.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: